Navigation Links
UT Arlington study links BPA and breast cancer tumor growth
Date:3/6/2014

UT Arlington biochemists say their newly published study brings researchers a step closer to understanding how the commonly used synthetic compound bisphenol-A, or BPA, may promote breast cancer growth.

Subhrangsu Mandal, associate professor of chemistry/biochemistry, and Arunoday Bhan, a PhD student in Mandal's lab, looked at a molecule called RNA HOTAIR. HOTAIR is an abbreviation for long, non-coding RNA, a part of DNA in humans and other vertebrates. HOTAIR does not produce a protein on its own but, when it is being expressed or functioning, it can suppress genes that would normally slow tumor growth or cause cancer cell death.

High levels of HOTAIR expression have been linked to breast tumors, pancreatic and colorectal cancers, sarcoma and others. UT Arlington researchers found that when breast cancer and mammary gland cells were exposed to BPA in lab tests, the BPA worked together with naturally present molecules, including estrogen, to create abnormal amounts of HOTAIR expression. Their results were published online in February by the Journal of Steroid Biochemistry and Molecular Biology.

"We can't immediately say BPA causes cancer growth, but it could well contribute because it is disrupting the genes that defend against that growth," said Mandal, who is corresponding author on the paper.

"Understanding the developmental impact of these synthetic hormones is an important way to protect ourselves and could be important for treatment," he said.

Bhan is lead author on the new paper. Co-authors include Mandal lab members Imran Hussain and Khairul I Ansari, as well as Linda I. Perrotti, a UT Arlington psychology assistant professor, and Samara A.M. Bobzean, a member of Perrotti's lab.

"We were surprised to find that BPA not only increased HOTAIR in tumor cells but also in normal breast tissue," said Bhan. He said further research is needed, but the results beg the question are BPA and HOTAIR involved in tumor genesis in addition to tumor growth?

BPA has been widely used in plastics, such as food storage containers, the lining of canned goods and, until recently, baby bottles. It belongs to a class of endocrine disrupting chemicals, or EDCs, which have been shown to mimic natural hormones. These endocrine disruptors interfere with hormone regulation and proper function of human cells, glands and tissue. Previous studies have linked BPA to problems with reproductive development, early puberty, obesity and cancers.

Under normal circumstances, estrogen regulates HOTAIR, turning its expression on and off through interaction with molecules called estrogen-receptors, or ERs, and estrogen receptor-coregulators, or ER-coregulators. The new study found that BPA disrupts the normal function of the ERs and the ER-coregulators when estrogen was present and when it wasn't, potentially implicating it in tumor growth in a variety of cancers.

"Research work is at its best when results can shed light on issues of public concern. Dr. Mandal and his team are using their expertise to do just that. Their findings continue to advance what we know about how the chemicals in our environment could be affecting us in unseen ways," said Pamela Jansma, dean of the UT Arlington College of Science.

Researchers saw similar results when they exposed HOTAIR to a synthetic estrogen called diethylstilbestrol (DES). DES has been shown to increase risks of breast cancer and other health problems in women who used it and their daughters. It was formerly used as a hormone replacement and as an attempt to prevent pregnancy complications.


'/>"/>
Contact: Traci Peterson
tpeterso@uta.edu
817-521-5494
University of Texas at Arlington
Source:Eurekalert  

Related biology news :

1. National herpetology society honors UT Arlington professor for discoveries
2. UT Arlington physics team demonstrates new power generation technique
3. National Academy of Inventors names four UT Arlington professors as charter fellows
4. UT Arlington engineer wins NSF award to support microfluidic analyses of tissue, cell samples
5. UT Arlington bioengineer to use hybrid imaging system to see deep tissue
6. UT Arlington engineer to search for bad algal blooms
7. UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline
8. UT Arlington engineer to design prototype that predicts flash flooding
9. 9 UT Arlington educators honored for teaching excellence
10. NSF awards to UT Arlington researchers will fuel sustainable solutions
11. UT Arlingtons Nguyen named American Heart Association fellow
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UT Arlington study links BPA and breast cancer tumor growth
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... ) - --> - Renvoi : image ... --> --> ... biométriques, fournit de nouveaux lecteurs d,empreintes digitales pour ... de DERMALOG sera utilisé pour produire des cartes ...
(Date:3/10/2016)...   Unisys Corporation (NYSE: UIS ) today ... is testing its biometric identity solution at the Otay Mesa ... help identify certain non-U.S. citizens leaving the country. ... help determine the efficiency and accuracy of using biometric technologies ... run until May 2016. --> the United ...
(Date:3/8/2016)...   Valencell , the leading innovator in ... secured $11M in Series D financing. The investment ... fund being launched by UAE-based financial services company ... TDF Ventures and WSJ Joshua Fund. Valencell plans ... growth and accelerate its pioneering innovation in accurate ...
Breaking Biology News(10 mins):
(Date:5/25/2016)... ... May 25, 2016 , ... The Ankle Plating ... options designed to address fractures of the distal tibia and fibula. This system ... Ankle Plating System 3 is composed of seven plate families that span the ...
(Date:5/25/2016)... ... May 25, 2016 , ... Scientists at the University of Athens say ... mesothelioma may be hampering the research that could lead to one good one. Surviving ... read it now. , The team evaluated 98 mesothelioma patients who ...
(Date:5/25/2016)... Connecticut (PRWEB) , ... May 25, 2016 , ... ... the U.S. Food and Drug Administration (FDA) has granted the company’s orphan drug ... the company’s second orphan drug designation granted by the FDA. , Spinocerebellar ...
(Date:5/24/2016)... ... ... Last week, Callan Capital, an integrated wealth management firm specializing in asset ... Diego Life Science event at the Estancia La Jolla Resort and Spa. , Over ... Dr. Rich Heyman, former CEO of Aragon and Seragon, and Faheem Hasnain, former CEO ...
Breaking Biology Technology: